European Archives - Page 40 of 1200 - European Medical Journal

Mitral Annular Remodelling Following HighLife Transcatheter Mitral Valve Replacement

Transcatheter mitral valve replacement (TMVR) using the HighLife TMVR system has demonstrated feasibility, an acceptable safety profile…

HEART Score and Coronary Artery Disease in Patients with Non-ST Acute Coronary Syndrome

The history, ECG, age, risk factors, and troponin (HEART) score was developed as a rapid risk stratification tool. It has five components…

Invasive Biventricular Physiology and Response after Transcatheter Mitral Repair

Mitral valve transcatheter edge-to-edge repair (M-TEER) has transformed the treatment of mitral regurgitation (MR) for high-risk patients…

Outcomes of Functionally Guided Drug-Coated Balloon versus Drug-Eluting Stent Percutaneous Coronary Intervention

Percutaneous coronary intervention (PCI), guided by physiological lesion assessment, has been shown to improve clinical outcomes by…

Spoonful of technology: April-June 2025

Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.

Using Biomarkers to Enhance Liver Transplant Medication Adherence

The biomarker identifies those at highest risk of non-adherence and helps determine how much support they receive during the intervention.

Aerobic or Resistance Training During Prostate Cancer Treatment?

Preliminary outcomes indicated that AE may improve haemoglobin levels, possibly counteracting androgen deprivation therapy induced reductions.

The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: June 2025

From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round up.

What Patients With Rheumatoid Arthritis Need to Know During Cancer

A new study highlights the pressing need for transparent communication and tailored education for patients managing both rheumatoid arthritis and cancer.

Gold crown on blue background

AstraZeneca ranks top in science graduates' survey

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for these graduates.